These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7112511)

  • 1. Contact activation by ellagic acid - the concept of soluble activator disputed.
    Exner T; Rickard KA
    Thromb Res; 1982 Apr; 26(2):83-9. PubMed ID: 7112511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of intrinsic blood coagulation by ellagic acid: insoluble ellagic acid-metal ion complexes are the activating species.
    Bock PE; Srinivasan KR; Shore JD
    Biochemistry; 1981 Dec; 20(25):7258-66. PubMed ID: 6797471
    [No Abstract]   [Full Text] [Related]  

  • 3. Rapid loss of factor XII and XI activity in ellagic acid-activated normal plasma: role of plasma inhibitors and implications for automated activated partial thromboplastin time recording.
    Joist JH; Cowan JF; Khan M
    J Lab Clin Med; 1977 Dec; 90(6):1054-65. PubMed ID: 303667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of ellagic acid-activated Hageman factor (factor XII) and Hageman factor fragments by popcorn inhibitor.
    Ratnoff OD; Moneme V
    Proc Soc Exp Biol Med; 1981 Feb; 166(2):297-9. PubMed ID: 7208489
    [No Abstract]   [Full Text] [Related]  

  • 5. Enhancement of pulmonary metastases following the intravenous infusion of a suspension of ellagic acid in traumatized rats.
    Agostino D; Agostino N
    Tumori; 1980 Jun; 66(3):285-93. PubMed ID: 7445109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The evolution of clot-promoting and amidolytic activities in mixtures of Hageman factor (factor XII) and ellagic acid.
    Ratnoff OD; Saito H
    J Lab Clin Med; 1982 Aug; 100(2):248-60. PubMed ID: 7097109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of N-nitrosobenzylmethylamine metabolism and DNA binding in cultured rat esophagus by ellagic acid.
    Mandal S; Shivapurkar NM; Galati AJ; Stoner GD
    Carcinogenesis; 1988 Jul; 9(7):1313-6. PubMed ID: 3383347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of inhibition of N-methyl-N-nitrosourea-induced mutagenicity and DNA binding by ellagic acid.
    Dixit R; Gold B
    IARC Sci Publ; 1987; (84):197-9. PubMed ID: 2445674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by hamster respiratory tissues cultured with ellagic acid.
    Castonguay A; Allaire L; Charest M; Rossignol G; Boutet M
    Cancer Lett; 1989 Jul; 46(2):93-105. PubMed ID: 2752387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of ellagic acid on the uptake, persistence, metabolism and DNA-binding of benzo[a]pyrene in cultured explants of strain A/J mouse lung.
    Teel RW; Dixit R; Stoner GD
    Carcinogenesis; 1985 Mar; 6(3):391-5. PubMed ID: 3978754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterizations of food-derived ellagic acid-Undaria pinnatifida polysaccharides solid dispersion and its benefits on solubility, dispersity and biotransformation of ellagic acid.
    Li ZR; Jia RB; Cai X; Luo D; Chen C; Zhao M
    Food Chem; 2023 Jul; 413():135530. PubMed ID: 36758386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of aflatoxin B1 mutagenesis in Salmonella typhimurium and DNA damage in cultured rat and human tracheobronchial tissues by ellagic acid.
    Mandal S; Ahuja A; Shivapurkar NM; Cheng SJ; Groopman JD; Stoner GD
    Carcinogenesis; 1987 Nov; 8(11):1651-6. PubMed ID: 3117405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effect of ellagic acid on N-2-fluorenylacetamide-induced liver carcinogenesis in male ACI/N rats.
    Tanaka T; Iwata H; Niwa K; Mori Y; Mori H
    Jpn J Cancer Res; 1988 Dec; 79(12):1297-303. PubMed ID: 2906931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analytical methods for assay of ellagic acid and its solubility studies.
    Bala I; Bhardwaj V; Hariharan S; Kumar MN
    J Pharm Biomed Anal; 2006 Jan; 40(1):206-10. PubMed ID: 16111850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ellagic acid: a potent naturally occurring inhibitor of benzo[a]pyrene metabolism and its subsequent glucuronidation, sulfation and covalent binding to DNA in cultured BALB/C mouse keratinocytes.
    Mukhtar H; Del Tito BJ; Marcelo CL; Das M; Bickers DR
    Carcinogenesis; 1984 Dec; 5(12):1565-71. PubMed ID: 6333937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary ellagic acid reduces the esophageal microsomal metabolism of methylbenzylnitrosamine.
    Barch DH; Fox CC
    Cancer Lett; 1989 Jan; 44(1):39-44. PubMed ID: 2917341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of N-methyl-N-nitrosourea-induced mutagenicity and DNA methylation by ellagic acid.
    Dixit R; Gold B
    Proc Natl Acad Sci U S A; 1986 Nov; 83(21):8039-43. PubMed ID: 3464940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of ellagic acid and 3-O-decylellagic acid on the formation of benzo[a]pyrene-derived DNA adducts in vivo and on the tumorigenicity of 3-methylcholanthrene in mice.
    Smart RC; Huang MT; Chang RL; Sayer JM; Jerina DM; Wood AW; Conney AH
    Carcinogenesis; 1986 Oct; 7(10):1669-75. PubMed ID: 3757169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of human plasma prekallikrein: influence of activators, activation time and temperature and inhibitors.
    Amundsen E; Gallimore MJ; Aasen AO; Larsbraaten M; Lyngaas K
    Thromb Res; 1978 Oct; 13(4):625-36. PubMed ID: 746527
    [No Abstract]   [Full Text] [Related]  

  • 20. APTT reagent with ellagic acid as activator shows adequate lupus anticoagulant sensitivity in comparison to silica-based reagent.
    Kumano O; Ieko M; Naito S; Yoshida M; Takahashi N
    J Thromb Haemost; 2012 Nov; 10(11):2338-43. PubMed ID: 22909048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.